Charles Schwab
EXAS

Charles Schwab’s Exact Sciences EXAS Stock Holding History

Charles Schwab’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,532,235
Closed -$156M – 3478
2025
Q4 		$156M Buy
1,532,235
+22,634
+1% +$1.82M 0.02% 515
2025
Q3 		$82.6M Buy
1,509,601
+74,746
+5% +$3.73M 0.01% 821
2025
Q2 		$76.2M Buy
1,434,855
+43,256
+3% +$2.2M 0.01% 825
2025
Q1 		$60.2M Buy
1,391,599
+60,660
+5% +$3.07M 0.01% 954
2024
Q4 		$74.8M Buy
1,330,939
+38,849
+3% +$2.42M 0.01% 823
2024
Q3 		$88M Buy
1,292,090
+45,015
+4% +$2.54M 0.02% 740
2024
Q2 		$52.7M Buy
1,247,075
+56,709
+5% +$3.12M 0.01% 1034
2024
Q1 		$82.2M Buy
1,190,366
+22,457
+2% +$1.42M 0.02% 700
2023
Q4 		$86.4M Buy
1,167,909
+30,831
+3% +$2.02M 0.02% 631
2023
Q3 		$77.6M Sell
1,137,078
-586
-0.1% -$49.7K 0.02% 622
2023
Q2 		$107M Buy
1,137,664
+17,555
+2% +$1.37M 0.03% 487
2023
Q1 		$76M Buy
1,120,109
+12,784
+1% +$822K 0.02% 600
2022
Q4 		$54.8M Buy
1,107,325
+62,783
+6% +$2.57M 0.02% 749
2022
Q3 		$33.9M Buy
1,044,542
+474,199
+83% +$19.6M 0.01% 1015
2022
Q2 		$22.5M Buy
570,343
+24,376
+4% +$1.3M 0.01% 1316
2022
Q1 		$38.2M Buy
545,967
+23,717
+5% +$1.73M 0.01% 1060
2021
Q4 		$40.6M Sell
522,250
-2,669
-0.5% -$236K 0.01% 1046
2021
Q3 		$50.1M Buy
524,919
+7,991
+2% +$844K 0.02% 868
2021
Q2 		$64.3M Buy
516,928
+16,649
+3% +$1.99M 0.02% 699
2021
Q1 		$65.9M Buy
500,279
+30,643
+7% +$4.19M 0.02% 664
2020
Q4 		$62.2M Buy
469,636
+24,026
+5% +$2.91M 0.02% 657
2020
Q3 		$45.4M Buy
445,610
+29,955
+7% +$2.59M 0.02% 707
2020
Q2 		$36.1M Buy
415,655
+46,398
+13% +$3.71M 0.02% 776
2020
Q1 		$21.4M Buy
369,257
+6,823
+2% +$554K 0.01% 969
2019
Q4 		$33.5M Buy
362,434
+31,144
+9% +$2.74M 0.02% 876
2019
Q3 		$29.9M Sell
331,290
-459,431
-58% -$52.3M 0.02% 894
2019
Q2 		$93.3M Buy
790,721
+36,316
+5% +$3.66M 0.06% 325
2019
Q1 		$65.3M Buy
754,405
+62,555
+9% +$5.32M 0.04% 418
2018
Q4 		$43.7M Buy
691,850
+636
+0.1% +$43.6K 0.03% 512
2018
Q3 		$54.6M Buy
691,214
+48,555
+8% +$3.17M 0.04% 495
2018
Q2 		$38.4M Sell
642,659
-187,433
-23% -$10.1M 0.03% 627
2018
Q1 		$33.5M Buy
830,092
+64,570
+8% +$3.15M 0.03% 679
2017
Q4 		$40.2M Buy
765,522
+41,784
+6% +$2.23M 0.03% 551
2017
Q3 		$34.1M Buy
723,738
+212,697
+42% +$8.56M 0.03% 578
2017
Q2 		$18.1M Buy
511,041
+27,192
+6% +$839K 0.02% 933
2017
Q1 		$11.4M Buy
483,849
+65,619
+16% +$1.3M 0.01% 1225
2016
Q4 		$5.59M Buy
418,230
+21,600
+5% +$349K 0.01% 1669
2016
Q3 		$7.37M Buy
396,630
+73,756
+23% +$1.3M 0.01% 1387
2016
Q2 		$3.96M Buy
322,874
+21,193
+7% +$160K ﹤0.01% 1708
2016
Q1 		$2.03M Sell
301,681
-26,032
-8% -$167K ﹤0.01% 2038
2015
Q4 		$3.02M Buy
327,713
+35,261
+12% +$328K ﹤0.01% 1849
2015
Q3 		$5.26M Buy
292,452
+27,699
+10% +$636K 0.01% 1430
2015
Q2 		$7.87M Buy
264,753
+14,403
+6% +$362K 0.01% 1217
2015
Q1 		$5.51M Buy
250,350
+24,178
+11% +$613K 0.01% 1442
2014
Q4 		$6.21M Buy
226,172
+2,704
+1% +$65.8K 0.01% 1271
2014
Q3 		$4.33M Buy
223,468
+9,840
+5% +$180K 0.01% 1496
2014
Q2 		$3.64M Buy
213,628
+19,686
+10% +$271K 0.01% 1627
2014
Q1 		$2.75M Buy
193,942
+14,874
+8% +$201K ﹤0.01% 1774
2013
Q4 		$2.09M Buy
179,068
+6,402
+4% +$73.4K ﹤0.01% 1895
2013
Q3 		$2.1M Buy
172,666
+27,863
+19% +$358K ﹤0.01% 1814
2013
Q2 		$2.09M Buy
+144,803
New +$1.57M ﹤0.01% 1730

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Charles Schwab's EXAS Position: Q1 2026 in Review

Charles Schwab sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,532,235 shares — an estimated $156M sold.

Charles Schwab first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $156M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Charles Schwab reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Charles Schwab sold 1,532,235 Exact Sciences shares in Q1 2026, an estimated $156M.
  • Charles Schwab first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Charles Schwab's Exact Sciences position peaked at $156M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.